Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy

References

• Hait NC, Maiti A. The role of sphingosine-1-Phosphate and ceramide-1-Phosphate in inflammation and cancer. Mediators Inflamm. 2017;2017:4806541.
   PubMed Web of Science ®Google Scholar
• Kurlansky P. Inflammation: the classic double-edged sword. J Thorac Cardiovasc Surg. 2015;149(3):866–868.
   PubMed Web of Science ®Google Scholar
• Arulselvan P, Fard MT, Tan WS, et al. Role of antioxidants and natural products in inflammation. Oxid Med Cell Longev. 2016;2016:5276130.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Sailo BL, Banik K, et al. Chronic diseases, inflammation, and spices: how are they linked? J Transl Med. 2018;16(1):14.
   PubMedGoogle Scholar
• Karin M, Clevers H. Reparative inflammation takes charge of tissue regeneration. Nature. 2016;529(7586):307–315.
   PubMed Web of Science ®Google Scholar
• Pombo García K, Zarschler K, Barbaro L, et al. Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. Small. 2014;10(13):2516–2529.
   PubMed Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–951.
   PubMed Web of Science ®Google Scholar
• Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41(7):2780–2799.
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang L. Engineering red-blood-cell-membrane-coated nanoparticles for broad biomedical applications. AIChE J. 2015;61(3):738–746.
   Web of Science ®Google Scholar
• Wang H, Liu Y, He R, et al. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery. Biomater Sci. 2020;8(2):552–568.
   PubMed Web of Science ®Google Scholar
• Wang Y. Fabrication of Macrophage Membrane-Coated Nanodrug and Its Applications in Anti-Atherosclerosis [doctoral thesis]. Chongqing: Chongqing Univ; 2019.
   Google Scholar
• Hettinger J, Richards DM, Hansson J, et al. Origin of monocytes and macrophages in a committed progenitor. Nat Immunol. 2013;14(8):821–830.
   PubMed Web of Science ®Google Scholar
• Dutta P, Nahrendorf M. Regulation and consequences of monocytosis. Immunol Rev. 2014;262(1):167–178.
   PubMed Web of Science ®Google Scholar
• Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325(5940):612–616.
   PubMed Web of Science ®Google Scholar
• Bashir S, Sharma Y, Elahi A, et al. Macrophage polarization: the link between inflammation and related d diseases. Inflamm Res. 2016;65(1):1–11.
   PubMed Web of Science ®Google Scholar
• Jiang X, Li Y, Han G. Progress on the role of the signal transducers and activators of transcription family molecules in the regulation of macrophage polarization. Int J Immunol. 2015;38(01):54–57.
   PubMedGoogle Scholar
• Feng Y, Feng H, Zhng L, et al. Research progress on synthesis and application of membrane-coated nanoparticles. Shandong Med J. 2020;60(09):104–107.
   Google Scholar
• Xuan M, Shao J, Dai L, et al. Macrophage cell membrane camouflaged mesoporous silica nanocapsules for in vivo cancer therapy. Adv Healthc Mater. 2015;4(11):1645–1652.
   PubMed Web of Science ®Google Scholar
• Chen HY, Deng J, Wang Y, et al. Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater. 2020;112:1–13.
   PubMed Web of Science ®Google Scholar
• Qiang L, Cai Z, Jiang W, et al. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. J Nanobiotechnology. 2019;17(1):83.
   PubMedGoogle Scholar
• Tao Y, Ning M, Dou H. A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery. Nanomedicine. 2013;9(2):222–232.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Gilbert JB, Kumar S, et al. Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. J Control Release. 2015;199:29–36.
   PubMed Web of Science ®Google Scholar
• Ou Z, Zhong H, Zhang L, et al. Macrophage membrane-coated nanoparticles alleviate hepatic ischemia-reperfusion injury caused by orthotopic liver transplantation by neutralizing endotoxin. Int J Nanomed. 2020;15:4125–4138.
   PubMed Web of Science ®Google Scholar
• Copp JA, Fang RH, Luk BT, et al. Clearance of pathological antibodies using biomimetic nanoparticles. Proc Natl Acad Sci USA. 2014;111(37):13481–13486.
   PubMed Web of Science ®Google Scholar
• Fang RH, Kroll AV, Gao W, et al. Cell membrane coating nanotechnology. Adv Mater. 2018;30(23):e1706759.
   PubMed Web of Science ®Google Scholar
• Shi W, Hu F, Yin T, et al. Research advancement of cell membrane biomimetic modified nanoparticles in tumor treatment. Prog Biochem Biophys. 2021;2021:1–28.
   Google Scholar
• Hu C, Wu Z, Gu F, et al. Cell membrane biomimetic nanoparticles in tumor therapy: research advances. Pract Pharm Clin Remed. 2021;24(09):843–847.
   Google Scholar
• Rao L, Cai B, Bu LL, et al. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano. 2017;11(4):3496–3505.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang W, Li Y, et al. Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting. Nano Lett. 2019;19(11):7836–7844.
   PubMed Web of Science ®Google Scholar
• Dhiman N, Awasthi R, Sharma B, et al. Lipid nanoparticles as carriers for bioactive delivery. Front Chem. 2021;9:580118.
   PubMed Web of Science ®Google Scholar
• Luo C, Hu X, Peng R, et al. Biomimetic carriers based on giant membrane vesicles for targeted drug delivery and photodynamic/photothermal synergistic therapy. ACS Appl Mater Interfaces. 2019;11(47):43811–43819.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang K, Li T, et al. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics. 2021;11(1):164–180.
   PubMed Web of Science ®Google Scholar
• Thamphiwatana S, Angsantikul P, Escajadillo T, et al. Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management. Proc Natl Acad Sci USA. 2017;114(43):11488–11493.
   PubMed Web of Science ®Google Scholar
• Rayamajhi S, Nguyen TDT, Marasini R, et al. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery. Acta Biomater. 2019;94:482–494.
   PubMed Web of Science ®Google Scholar
• Chen LJ, Zhao X, Liu YY, et al. Macrophage membrane coated persistent luminescence nanoparticle@MOF-derived mesoporous carbon core-shell nanocomposites for autofluorescence-free imaging-guided chemotherapy. J Mater Chem B. 2020;8(35):8071–8083.
   PubMed Web of Science ®Google Scholar
• Yu H, Yang Z, Li F, et al. Cell-mediated targeting drugs delivery systems. Drug Deliv. 2020;27(1):1425–1437.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Gendelman HE, Kabanov AV. Cell-mediated drug delivery. Expert Opin Drug Deliv. 2011;8(4):415–433.
   PubMed Web of Science ®Google Scholar
• Gao L, Wang H, Nan L, et al. Erythrocyte Membrane-Wrapped pH sensitive polymeric nanoparticles for non-small cell lung cancer therapy. Bioconjug Chem. 2017;28(10):2591–2598.
   PubMed Web of Science ®Google Scholar
• Ikehara Y, Niwa T, Biao L, et al. A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 2006;66(17):8740–8748.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhang R, Li C, et al. A targeting nanotherapy for abdominal aortic aneurysms. J Am Coll Cardiol. 2018;72(21):2591–2605.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cai K, Li C, et al. Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy. Nano Lett. 2018;18(3):1908–1915.
   PubMed Web of Science ®Google Scholar
• Williams JW, Huang LH, Randolph GJ. Cytokine circuits in cardiovascular disease. Immunity. 2019;50(4):941–954.
   PubMed Web of Science ®Google Scholar
• Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J. 2011;75(12):2739–2748.
   PubMed Web of Science ®Google Scholar
• Hasturk H, Kantarci A, Van Dyke TE. Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol. 2012;3:118.
   PubMed Web of Science ®Google Scholar
• Baek SK, Makkouk AR, Krasieva T, et al. Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells. J Neurooncol. 2011;104(2):439–448.
   PubMed Web of Science ®Google Scholar
• Madsen SJ, Christie C, Hong SJ, et al. Nanoparticle-loaded macrophage-mediated photothermal therapy: potential for glioma treatment. Lasers Med Sci. 2015;30(4):1357–1365.
   PubMed Web of Science ®Google Scholar
• Li R, He Y, Zhu Y, et al. Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano Lett. 2019;19(1):124–134.
   PubMed Web of Science ®Google Scholar
• Cao X, Tan T, Zhu D, et al. Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for targeted cancer therapy. Int J Nanomed. 2020;15:1915–1928.
   PubMed Web of Science ®Google Scholar
• Wei X, Gao J, Fang RH, et al. Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials. 2016;111:116–123.
   PubMed Web of Science ®Google Scholar
• Turato C, Balasso A, Carloni V, et al. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma. J Control Release. 2017;268:184–197.
   PubMed Web of Science ®Google Scholar
• Li PY, Fan Z, Cheng H. Cell membrane bioconjugation and membrane-derived nanomaterials for immunotherapy. Bioconjug Chem. 2018;29(3):624–634.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy S, Gnanasammandhan MK, Xie C, et al. Monocyte cell membrane-derived nanoghosts for targeted cancer therapy. Nanoscale. 2016;8(13):6981–6985.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–760.
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9):771–782.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003;42(5):419–436.
   PubMed Web of Science ®Google Scholar
• Papaldo P, Fabi A, Ferretti G, et al. A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease. Ann Oncol. 2006;17(4):630–636.
   PubMed Web of Science ®Google Scholar
• Knop K, Hoogenboom R, Fischer D, et al. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl. 2010;49(36):6288–6308.
   PubMed Web of Science ®Google Scholar
• Xuan M, Shao J, Dai L, et al. Macrophage cell membrane camouflaged Au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces. 2016;8(15):9610–9618.
   PubMed Web of Science ®Google Scholar
• Brynskikh AM, Zhao Y, Mosley RL, et al. Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine. 2010;5(3):379–396.
   PubMed Web of Science ®Google Scholar
• Moura RP, Almeida A, Sarmento B. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier. Prog Neurobiol. 2017;159:39–49.
   PubMed Web of Science ®Google Scholar
• Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9(6):540–549.
   PubMed Web of Science ®Google Scholar
• Obermeier B, Verma A, Ransohoff RM. The blood-brain barrier. Handb Clin Neurol. 2016;133:39–59.
   PubMedGoogle Scholar
• Klyachko NL, Haney MJ, Zhao Y, et al. Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins. Nanomedicine. 2014;9(9):1403–1422.
   PubMed Web of Science ®Google Scholar
• Pawlowski NA, Kaplan G, Abraham E, et al. The selective binding and transmigration of monocytes through the junctional complexes of human endothelium. J Exp Med. 1988;168(5):1865–1882.
   PubMed Web of Science ®Google Scholar
• Choi MR, Bardhan R, Stanton-Maxey KJ, et al. Delivery of nanoparticles to brain metastases of breast cancer using a cellular trojan horse. Cancer Nanotechnol. 2012;3(1–6):47–54.
   PubMedGoogle Scholar
• Tong HI, Kang W, Davy PM, et al. Monocyte trafficking, engraftment, and delivery of nanoparticles and an exogenous gene into the acutely inflamed brain tissue – evaluations on monocyte-based delivery system for the central nervous system. PLOS One. 2016;11(4):e0154022.
   PubMed Web of Science ®Google Scholar
• Pang L, Qin J, Han L, et al. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma. Oncotarget. 2016;7(24):37081–37091.
   PubMedGoogle Scholar
• Wang Z, Li J, Cho J, et al. Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils. Nat Nanotechnol. 2014;9(3):204–210.
   PubMed Web of Science ®Google Scholar
• Ye S, Wang F, Fan Z, et al. Light/pH-Triggered biomimetic red blood cell membranes camouflaged small molecular drug assemblies for imaging-guided combinational chemo-photothermal therapy. ACS Appl Mater Interfaces. 2019;11(17):15262–15275.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Luk BT, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14(4):2181–2188.
   PubMed Web of Science ®Google Scholar
• Zhang B, Sai Lung P, Zhao S, et al. Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells. Sci Rep. 2017;7(1):7315.
   PubMedGoogle Scholar
• Torres N, Guevara-Cruz M, Velázquez-Villegas LA, et al. Nutrition and atherosclerosis. Arch Med Res. 2015;46(5):408–426.
   PubMed Web of Science ®Google Scholar
• Schaftenaar F, Frodermann V, Kuiper J, et al. Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol. 2016;27(3):209–215.
   PubMed Web of Science ®Google Scholar
• Wang D, Yang Y, Lei Y, et al. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev. 2019;71(4):596–670.
   PubMed Web of Science ®Google Scholar
• Liu X, Wu J, Tian R, et al. Targeting foam cell formation and macrophage polarization in atherosclerosis: the therapeutic potential of rhubarb. Biomed Pharmacother. 2020;129:110433.
   PubMed Web of Science ®Google Scholar
• Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med. 2014;46(6):e99.
   PubMed Web of Science ®Google Scholar
• Wang T, Sun C, Hu L, et al. Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells. Biochem Cell Biol. 2020;98(2):120–129.
   PubMedGoogle Scholar
• Cheng L, Li C. A preliminary study on the biomimetic drug delivery system targeting atherosclerotic lesions. Acta Pharm Sin. 2018;53(02):297–303.
   Google Scholar
• Gao C, Huang Q, Liu C, et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat Commun. 2020;11(1):2622.
   PubMed Web of Science ®Google Scholar
• Diakos CI, Charles KA, McMillan DC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493-503–e503.
   PubMed Web of Science ®Google Scholar
• Singh R, Mishra MK, Aggarwal H. Inflammation, immunity, and cancer. Mediators Inflamm. 2017;2017:6027305.
   PubMed Web of Science ®Google Scholar
• Li C, Xu X, Wei S, et al. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J Immunother Cancer. 2021;9(1):e001341.
   PubMed Web of Science ®Google Scholar
• Yunna C, Mengru H, Lei W, et al. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090.
   PubMed Web of Science ®Google Scholar
• Xia Y, Rao L, Yao H, et al. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32(40):e2002054.
   PubMed Web of Science ®Google Scholar
• Tariq M, Zhang JQ, Liang GK, et al. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway. Acta Pharmacol Sin. 2017;38(11):1501–1511.
   PubMed Web of Science ®Google Scholar
• Pang L, Zhu Y, Qin J, et al. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy. Drug Deliv. 2018;25(1):1922–1931.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Suresh P, Zhao Y, et al. Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery. Nanomedicine. 2012;7(6):815–833.
   PubMed Web of Science ®Google Scholar
• Hong S, Banks WA. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain Behav Immun. 2015;45:1–12.
   PubMed Web of Science ®Google Scholar
• Mukhara D, Oh U, Neigh GN. Neuroinflammation. Handb Clin Neurol. 2020;175:235–259.
   PubMedGoogle Scholar
• Ho MS. Microglia in Parkinson's disease. Adv Exp Med Biol. 2019;1175:335–353.
   PubMed Web of Science ®Google Scholar
• Forloni G, La Vitola P, Cerovic M, et al. Inflammation and Parkinson's disease pathogenesis: mechanisms and therapeutic insight. Prog Mol Biol Transl Sci. 2021;177:175–202.
   PubMed Web of Science ®Google Scholar
• Falasca K, Reale M, Ucciferri C, et al. Cytokines, hepatic fibrosis, and antiretroviral therapy role in neurocognitive disorders HIV related. AIDS Res Hum Retroviruses. 2017;33(3):246–253.
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Gendelman HE. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol. 2003;74(5):691–701.
   PubMed Web of Science ®Google Scholar
• Singh MV, Davidson DC, Jackson JW, et al. Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation. J Immunol. 2014;192(10):4674–4684.
   PubMed Web of Science ®Google Scholar
• Joseph SB, Arrildt KT, Sturdevant CB, et al. HIV-1 target cells in the CNS. J Neurovirol. 2015;21(3):276–289.
   PubMed Web of Science ®Google Scholar
• Williams DW, Eugenin EA, Calderon TM, et al. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol. 2012;91(3):401–415.
   PubMed Web of Science ®Google Scholar
• Dou H, Grotepas CB, McMillan JM, et al. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol. 2009;183(1):661–669.
   PubMed Web of Science ®Google Scholar
• Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28(1):26–42.
   PubMed Web of Science ®Google Scholar
• van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407–420.
   PubMed Web of Science ®Google Scholar
• Yaroustovsky M, Plyushch M, Popov D, et al. Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery. J Inflamm. 2013;10(1):8.
   Google Scholar
• Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202(3):361–370.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637–650.
   PubMed Web of Science ®Google Scholar
• Hagar JA, Powell DA, Aachoui Y, et al. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science. 2013;341(6151):1250–1253.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang Y, Zhang L, et al. Pretreated macrophage-membrane-coated gold nanocages for precise drug delivery for treatment of bacterial infections. Adv Mater. 2018;30(46):e1804023.
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108.
   PubMed Web of Science ®Google Scholar
• Yang X, Chang Y, Wei W. Emerging role of targeting macrophages in rheumatoid arthritis: focus on polarization, metabolism and apoptosis. Cell Prolif. 2020;53(7):e12854.
   PubMed Web of Science ®Google Scholar
• Tardito S, Martinelli G, Soldano S, et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a systematic review. Autoimmun Rev. 2019;18(11):102397.
   PubMed Web of Science ®Google Scholar
• Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014;14(6):392–404.
   PubMed Web of Science ®Google Scholar
• Elshabrawy HA, Chen Z, Volin MV, et al. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis. 2015;18(4):433–448.
   PubMed Web of Science ®Google Scholar
• Asagiri M, Takayanagi H. The molecular understanding of osteoclast differentiation. Bone. 2007;40(2):251–264.
   PubMed Web of Science ®Google Scholar
• Chan YC, Leung PS. Acute pancreatitis: animal models and recent advances in basic research. Pancreas. 2007;34(1):1–14.
   PubMed Web of Science ®Google Scholar
• Wu XB, Sun HY, Luo ZL, et al. Plasma-derived exosomes contribute to pancreatitis-associated lung injury by triggering NLRP3-dependent pyroptosis in alveolar macrophages. Biochim Biophys Acta Mol Basis Dis. 2020;1866(5):165685.
   PubMed Web of Science ®Google Scholar
• Papachristou GI. Prediction of severe acute pancreatitis: current knowledge and novel insights. World J Gastroenterol. 2008;14(41):6273–6275.
   PubMed Web of Science ®Google Scholar
• Shrivastava P, Bhatia M. Essential role of monocytes and macrophages in the progression of acute pancreatitis. World J Gastroenterol. 2010;16(32):3995–4002.
   PubMed Web of Science ®Google Scholar
• Qiao W, Cao X, Zhang Z, et al. Celastrol-loaded macrophage membrane camouflaged PEG-PLGA nano-particles for targeted therapy of severe acute pancreatitis in rats. Acta Pharm Sin. 2018;53(01):127–132.
   Google Scholar
• Fu J, Wang D, Mei D, et al. Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. J Control Release. 2015;204:11–19.
   PubMed Web of Science ®Google Scholar
• Li H. Piperine liposome cotated with isolated macrophage membrane inhibit proliferation, invastasis of breast cancer cells [master’s thesis]. Chongqing: Chongqing Med Univ; 2019.
   Google Scholar
• Cao H, Dan Z, He X, et al. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano. 2016;10(8):7738–7748.
   PubMed Web of Science ®Google Scholar
• Liang B, Deng T, Li J, et al. Biomimetic theranostic strategy for anti-metastasis therapy of breast cancer via the macrophage membrane camouflaged superparticles. Mater Sci Eng C Mater Biol Appl. 2020;115:111097.
   PubMed Web of Science ®Google Scholar
• Zhao H, Li L, Zhang J, et al. C-C Chemokine Ligand 2 (CCL2) recruits macrophage-membrane-camouflaged hollow bismuth selenide nanoparticles to facilitate photothermal sensitivity and inhibit lung metastasis of breast cancer. ACS Appl Mater Interfaces. 2018;10(37):31124–31135.
   PubMed Web of Science ®Google Scholar
• Li TF, Li K, Wang C, et al. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. J Control Release. 2017;268:128–146.
   PubMed Web of Science ®Google Scholar
• Pall AE, Juratli L, Guntur D, et al. A gain of function paradox: targeted therapy for glioblastoma associated with abnormal NHE9 expression. J Cell Mol Med. 2019;23(11):7859–7872.
   PubMed Web of Science ®Google Scholar
• Wang P. Preparation of Macrophage Membrane Coated Drug-loaded PLGA Nanoparticles and Experimental Study on Targeting of CT26 Cells [master’s thesis]. Wuhan: Huazhong Univ Sci Technol; 2019.
   Google Scholar
• Ji B, Cai H, Yang Y, et al. Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma. Acta Biomater. 2020;111:363–372.
   PubMed Web of Science ®Google Scholar